A. V. van Golde

Natalizumab treatment shows low cumulative probabilities of confirmed disability worsening to EDSS milestones in the long-term setting.

David K Howse, A. Verier, M. Valis, 2018, Multiple sclerosis and related disorders.

PML-IRIS during Fingolimod Diagnosed after Natalizumab Discontinuation

M. Wattjes, J. Killestein, A. V. van Golde, 2014, Case reports in neurological medicine.

MRI pattern in asymptomatic natalizumab-associated PML

F. Barkhof, M. Steenwijk, N. Richert, 2014, Journal of Neurology, Neurosurgery & Psychiatry.